MDT
99.8
-0.46%↓
A
147.83
+0.18%↑
VEEV
238.66
+0.24%↑
HQY
97.62
+2.79%↑
PHR.US
17.5
+1.74%↑
MDT
99.8
-0.46%↓
A
147.83
+0.18%↑
VEEV
238.66
+0.24%↑
HQY
97.62
+2.79%↑
PHR.US
17.5
+1.74%↑
MDT
99.8
-0.46%↓
A
147.83
+0.18%↑
VEEV
238.66
+0.24%↑
HQY
97.62
+2.79%↑
PHR.US
17.5
+1.74%↑
MDT
99.8
-0.46%↓
A
147.83
+0.18%↑
VEEV
238.66
+0.24%↑
HQY
97.62
+2.79%↑
PHR.US
17.5
+1.74%↑
MDT
99.8
-0.46%↓
A
147.83
+0.18%↑
VEEV
238.66
+0.24%↑
HQY
97.62
+2.79%↑
PHR.US
17.5
+1.74%↑
24h
Šī brīža
Min
Max
Ienākumi | -1.5M -6M |
|---|---|
Pārdošana | -291K 201K |
EPS | -1.14 |
Peļņas marža | -2,971.144 |
Darbinieki | 32 |
EBITDA | -1.7M -3.3M |
Nākamie ieņēmumi | 2026. g. 26. marts |
|---|
Tirgus kapitalizācija | -17M 2.1M |
|---|---|
Iepriekšējā atvēršanas cena | 0.35 |
Iepriekšējā slēgšanas cena | 0.35 |
By Trading Central
Pārliecība
Neutral Evidence
0.8417 / 0.8939 Atbalsts un pretestība
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
2026. g. 7. janv. 23:11 UTC
Samsung Electronics Expects Record Fourth-Quarter Profit Beat
DJ
Lasīt
2026. g. 7. janv. 22:55 UTC
Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027
DJ
Lasīt
2026. g. 7. janv. 21:39 UTC
Raytheon Down Following Trump Post Criticizing Company
DJ
Lasīt
2026. g. 7. janv. 20:13 UTC
AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition
DJ
Lasīt
2026. g. 7. janv. 20:03 UTC
Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay
DJ
Lasīt
2026. g. 7. janv. 23:46 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Lasīt
2026. g. 7. janv. 23:46 UTC
Nikkei May Decline as China-Japan Tensions Linger -- Market Talk
DJ
Lasīt
2026. g. 7. janv. 23:42 UTC
Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update
DJ
Lasīt
2026. g. 7. janv. 23:34 UTC
Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk
DJ
Lasīt
2026. g. 7. janv. 23:29 UTC
Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com
DJ
Lasīt
2026. g. 7. janv. 22:48 UTC
Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk
DJ
Lasīt
2026. g. 7. janv. 22:46 UTC
Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE
DJ
Lasīt
2026. g. 7. janv. 22:45 UTC
Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE
DJ
Lasīt
2026. g. 7. janv. 22:43 UTC
Revolution Medicines Draws Takeover Interest -- 2nd Update
DJ
Lasīt
2026. g. 7. janv. 22:42 UTC
Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast
DJ
Lasīt
2026. g. 7. janv. 22:41 UTC
Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE
DJ
Lasīt
2026. g. 7. janv. 22:41 UTC
Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE
DJ
Lasīt
2026. g. 7. janv. 22:40 UTC
Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027
DJ
Lasīt
2026. g. 7. janv. 22:31 UTC
Macro Tailwinds Strengthen for Chalice Mining -- Market Talk
DJ
Lasīt
2026. g. 7. janv. 22:22 UTC
Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk
DJ
Lasīt
2026. g. 7. janv. 22:01 UTC
Valuations of New Zealand Property Stocks Supportive -- Market Talk
DJ
Lasīt
2026. g. 7. janv. 21:50 UTC
Basic Materials Roundup: Market Talk
DJ
Lasīt
2026. g. 7. janv. 21:46 UTC
Northern Star's Revised Guidance Looks Achievable -- Market Talk
DJ
Lasīt
2026. g. 7. janv. 21:22 UTC
Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX
DJ
Lasīt
2026. g. 7. janv. 21:18 UTC
Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX
DJ
Lasīt
2026. g. 7. janv. 21:05 UTC
Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update
DJ
Lasīt
2026. g. 7. janv. 20:29 UTC
AbbVie Near Deal for Revolution Medicines -- Update
DJ
Lasīt
2026. g. 7. janv. 20:27 UTC
U.S. Natural Gas Futures Snap Losing Streak -- Market Talk
DJ
Lasīt
2026. g. 7. janv. 19:58 UTC
Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk
DJ
Lasīt
2026. g. 7. janv. 19:48 UTC
Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay
DJ
Lasīt
Cenas izmaiņa
By TipRanks
Neitrāls
1 ratings
0
Pirkt
1
Turēt
0
Pārdot
Pamatojoties uz 1 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Clearside Biomedical Inc — pēdējo 3 mēnešu laikā.
By Trading Central
Īstermiņā
Neutral Evidence
The bullish and bearish events are balanced.
Vidējā termiņā
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Ilgtermiņā
Weak Bearish Evidence
There is one bearish event.
Pārdošanas un administrēšanas izmaksas
Darbības izmaksas
Peļņa pirms nodokļu nomaksas
Pārdošana
Pārdošanas maksa
Bruto peļņa no pārdošanas
Procentu izdevumi par parādu
EBITDA
Pamatdarbības peļņa
$